Welcome to our dedicated page for Nuburu SEC filings (Ticker: BURUW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Nuburu's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Nuburu's regulatory disclosures and financial reporting.
Nuburu, Inc. (BURUW) filed a Form 424B4 prospectus describing an offering of Pre-Funded Warrants and Common Warrants and disclosing material corporate and financing developments. The document sets placement agent fees at up to 7.5% on gross proceeds up to $10,000,000 and an additional 6.0% on amounts above $10,000,000. It warns investors of immediate dilution, potential cashless warrant exercises that amplify dilution, and that the company will likely need additional capital even if the offering is successful. The filing discloses numerous unsecured convertible notes issued in 2025 with conversion prices tied to discounted VWAPs, an Agile Note bearing 44% interest with weekly repayments through November 2025, and multiple financings and exchanges with Indigo Capital, Brick Lane, Bomore, Torcross and others. The company has received an NYSE American notice of noncompliance regarding delisting proceedings for its Public Warrants, recorded material weaknesses and restatements tied to debt accounting, and large potential share issuances from conversions/options/notes that could substantially dilute shareholders. The prospectus also highlights product advantages of its blue laser technology and strategic focus on defense licensing.